bacterial therapy therapeutic use bacteria treat diseases bacterial therapeutics living medicines may wild type bacteria often form probiotics bacteria genetically engineered possess therapeutic properties injected examples living medicines include cellular therapeutics including immunotherapeutics activators antitumor immunity synergizing existing tools approaches phage therapeutics delivery vehicles treatment diagnosis imaging complementing synergizing existing tools approaches development bacterial therapeutics extremely active research area fields synthetic biology currently large focus identifying bacteria naturally produce therapeutic effects example probiotic bacteria genetically programming bacteria produce therapeutic several aspects require consideration design engineered bacterial therapeutic selection chassis organism guided desired site activity pharmacokinetic properties chassis well manufacturing feasibility design genetic circuits may also influenced circuits effectors pragmatic concerns regarding inducer compounds genetic stability regulatory circuits critically design engineered bacterial drug may also constrained considerations needs patientscitation needed optimal strain design often requires balance strain suitability function target microenvironment concerns feasibility manufacturing clinical development workflow incorporate technologies optimizing strain potency well predictive vitro vivo assays well quantitative pharmacology models maximize translational potential patient tremendous interest using bacteria therapy treat tumors particular tumorhoming bacteria thrive hypoxic environments particularly attractive purpose tend migrate invade leaky vasculature tumor microenvironment colonize tumors property tends increase residence time tumor giving longer exert therapeutic effects contrast bacteria would quickly cleared immune addition colonized bacteria lyze tumor activate antitumor immune response engineered delivery vehicle anticancer therapeutics may potential contrast agents cancer imaging microbialbased cancer therapy may offer opportunity address issue global cancer therapy disparity introduce suitable cancer immunotherapy approach low middleincome systemic administration bacteria localize tumor microenvironment interactions bacteria cancer cells surrounding microenvironment cause various alterations tumorinfiltrating immune cells cytokines chemokines facilitate tumor regression bacterial toxins typhimurium listeria clostridium kill tumor cells directly inducing apoptosis autophagy toxins delivered via salmonella upregulate connexin leading bacteriainduced gap junctions tumor dendritic cells dcs allow crosspresentation tumor antigens dcs upon exposure tumor antigens interaction bacterial components dcs secrete robust amounts proinflammatory cytokine subsequently activates cells antitumor response activated cells enhanced bacterial flagellin protein subunit bacterial flagellum via activation perforin granzyme proteins secreted activated cells efficiently kill tumor cells primary metastatic tumors flagellin signaling also decreases abundance regulatory treg cells subsequently improves antitumor response activated cells typhimurium flagellin stimulates nk cells produce interferonγ ifnγ important cytokine innate adaptive immunity listeriainfected mdscs shift immunestimulating phenotype characterized increased production enhances nk cell responses typhimurium clostridium infection stimulate significant neutrophil accumulation elevated secretion tnfα tnfrelated apoptosisinducing ligand trail neutrophils enhances immune response kills tumor cells inducing apoptosis macrophage inflammasome activated contact bacterial components lps flagellin salmonelladamaged cancer cells leading elevated secretion tnfα tumor microenvironment nk cell natural killer cell treg cell regulatory cell mdscs myeloidderived suppressor cells receptor purinoceptor atp receptor lps considerable interest using bacterial therapeutics alter human gastrointestinal microbiota would helpful treating diseases like small intestinal bacterial overgrowth gut dysbiosis associated pathogenesis food forms dysbiosis httpsenwikipediaorgwikibacterialtherapy